HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intraabdominal urokinase in the treatment of loculated infected ascites in cirrhosis.

Abstract
Cirrhotic patients may present loculated ascites. We report a case of a 49-years old patient with cirrhosis and loculated infected ascites. Conventional and ultrasound (US)-guided paracentesis were ineffective. Moreover, US-guided drainages with 10 F drains could drain only small quantities of ascites localized in the largest loculated areas. Despite an adapted and long antibiotic therapy, the infection persisted. Intraabdominal fibrinolysis allowed the destruction of the fibrin septa, a better drainage and the sterilization of the ascites fluid. This is the first case report of effective intraabdominal fibrinolysis with urokinase in difficult to treat loculated infected ascites.
AuthorsSimona Tripon, Pierre Mayer, Axenia Svab, François Habersetzer, Patrick Pessaux, Thomas F Baumert, Iulian Enescu
JournalClinics and research in hepatology and gastroenterology (Clin Res Hepatol Gastroenterol) Vol. 45 Issue 2 Pg. 101486 (Mar 2021) ISSN: 2210-741X [Electronic] France
PMID32654936 (Publication Type: Case Reports)
CopyrightCopyright © 2020. Published by Elsevier Masson SAS.
Chemical References
  • Urokinase-Type Plasminogen Activator
Topics
  • Ascites (etiology, therapy)
  • Ascitic Fluid
  • Humans
  • Liver Cirrhosis (complications)
  • Middle Aged
  • Paracentesis
  • Urokinase-Type Plasminogen Activator

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: